{"id":38315,"date":"2026-03-30T08:49:11","date_gmt":"2026-03-30T06:49:11","guid":{"rendered":"https:\/\/ggba.swiss\/biomerieux-invests-in-plair-to-advance-environmental-monitoring-in-pharma\/"},"modified":"2026-03-30T08:53:09","modified_gmt":"2026-03-30T06:53:09","slug":"biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/","title":{"rendered":"bioM\u00e9rieux investit dans Plair pour moderniser la surveillance pharmaceutique"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.biomerieux.com\/corp\/fr.html\">bioM\u00e9rieux<\/a>, leader mondial du diagnostic in vitro dont le si\u00e8ge est \u00e0 Marcy-l&rsquo;\u00c9toile, en France, a annonc\u00e9 un investissement de plus de CHF 1 million dans <a href=\"https:\/\/www.plair.ch\">Plair<\/a>, une scale-up genevoise d\u00e9veloppant des solutions de d\u00e9tection microbienne et d&rsquo;\u00e9chantillonnage de l&rsquo;air en temps r\u00e9el. Cet investissement marque une expansion strat\u00e9gique de l&rsquo;offre de contr\u00f4le qualit\u00e9 pharmaceutique de bioM\u00e9rieux et \u00e9tablit un partenariat formel entre les deux soci\u00e9t\u00e9s. Dans le cadre de cette collaboration, Michael Reynier, Senior Vice President Pharma Quality Control chez bioM\u00e9rieux, rejoindra le conseil d&rsquo;administration de Plair.<\/p>\n\n\n\n<p>Fond\u00e9e en tant que spin-off de l&rsquo;<a href=\"https:\/\/www.unige.ch\">Universit\u00e9 de Gen\u00e8ve<\/a>, Plair est sp\u00e9cialis\u00e9e dans les syst\u00e8mes professionnels de surveillance environnementale utilisant une technologie de d\u00e9tection laser propri\u00e9taire capable d&rsquo;identifier en temps r\u00e9el des allerg\u00e8nes, des polluants atmosph\u00e9riques, des bact\u00e9ries et des a\u00e9rosols viraux. Son produit phare, RAPID-C+, est un compteur de particules viables en temps r\u00e9el unique en son genre, qui combine le comptage total et viable des particules avec un \u00e9chantillonnage continu certifi\u00e9 sur des milieux g\u00e9los\u00e9s standards, permettant l&rsquo;identification microbienne et soutenant une prise de d\u00e9cision plus rapide et mieux inform\u00e9e dans les environnements de salles blanches pharmaceutiques. Le produit est d\u00e9j\u00e0 disponible sur le march\u00e9.<\/p>\n\n\n\n<p>Ce partenariat r\u00e9pond \u00e0 un besoin croissant dans la fabrication pharmaceutique, o\u00f9 la surveillance environnementale dans les salles blanches est soumise \u00e0 des exigences r\u00e9glementaires de plus en plus strictes. La m\u00e9thodologie de comptage des particules biofluorescentes de RAPID-C+ repr\u00e9sente une nouvelle approche \u00e0 ce d\u00e9fi, et l&rsquo;approbation de bioM\u00e9rieux devrait acc\u00e9l\u00e9rer son acceptation r\u00e9glementaire et son adoption par l&rsquo;industrie.<\/p>\n\n\n\n<p>Cet investissement s&rsquo;appuie sur le soutien institutionnel ant\u00e9rieur de Plair, notamment un <a href=\"https:\/\/ggba.swiss\/fr\/trois-projets-genevois-innovants-remportent-un-financement-du-fif\/\">pr\u00eat de croissance de CHF 300&rsquo;000 accord\u00e9 par le Fonds d&rsquo;Innovation FONGIT en 2023<\/a>, et renforce le positionnement de Gen\u00e8ve comme p\u00f4le de r\u00e9f\u00e9rence pour la d\u00e9tection environnementale de pr\u00e9cision et l&rsquo;innovation dans les sciences de la vie. Pr\u00e9sent dans plus de 160 pays, bioM\u00e9rieux offre \u00e0 Plair une plateforme commerciale mondiale pour d\u00e9ployer sa technologie \u00e0 l&rsquo;\u00e9chelle de l&rsquo;industrie pharmaceutique.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le leader mondial du diagnostic in vitro bioM\u00e9rieux a investi plus d&rsquo;un million de francs suisses dans la scale-up Plair, dont le syst\u00e8me RAPID-C+ \u00e9tablit une nouvelle norme pour la surveillance en temps r\u00e9el des particules viables dans les salles blanches pharmaceutiques.<\/p>\n","protected":false},"author":6,"featured_media":38312,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1210,1188,1184,1170,1171],"class_list":["post-38315","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-diagnostic-fr-2","tag-healthcare-fr-2","tag-infrastructures-fr-2","tag-manufacturing-fr-2","tag-pharma-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>bioM\u00e9rieux investit plus de CHF 1 milllion dans Plair | GGBa<\/title>\n<meta name=\"description\" content=\"Le leader mondial du diagnostic in vitro bioM\u00e9rieux a investi plus d&#039;un million de francs suisses dans la scale-up Plair.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"bioM\u00e9rieux investit plus de CHF 1 milllion dans Plair | GGBa\" \/>\n<meta property=\"og:description\" content=\"Le leader mondial du diagnostic in vitro bioM\u00e9rieux a investi plus d&#039;un million de francs suisses dans la scale-up Plair.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-30T06:49:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-30T06:53:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Plair-Rapid-C-Plus-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"bioM\u00e9rieux investit dans Plair pour moderniser la surveillance pharmaceutique\",\"datePublished\":\"2026-03-30T06:49:11+00:00\",\"dateModified\":\"2026-03-30T06:53:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/\"},\"wordCount\":392,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Plair-Rapid-C-Plus-1180x811-1.png\",\"keywords\":[\"Biotech\",\"Diagnostic\",\"Healthcare\",\"Infrastructures\",\"Manufacturing\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/\",\"name\":\"bioM\u00e9rieux investit plus de CHF 1 milllion dans Plair | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Plair-Rapid-C-Plus-1180x811-1.png\",\"datePublished\":\"2026-03-30T06:49:11+00:00\",\"dateModified\":\"2026-03-30T06:53:09+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Le leader mondial du diagnostic in vitro bioM\u00e9rieux a investi plus d'un million de francs suisses dans la scale-up Plair.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Plair-Rapid-C-Plus-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Plair-Rapid-C-Plus-1180x811-1.png\",\"width\":1180,\"height\":811,\"caption\":\"Le syst\u00e8me RAPID-C+ de Plair combine le comptage en temps r\u00e9el des particules viables et totales avec un \u00e9chantillonnage continu certifi\u00e9 sur des milieux g\u00e9los\u00e9s standards, permettant une identification microbienne et une prise de d\u00e9cision plus rapide et mieux inform\u00e9e dans les environnements de salles blanches pharmaceutiques. | \u00a9 Plair\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"bioM\u00e9rieux investit dans Plair pour moderniser la surveillance pharmaceutique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"bioM\u00e9rieux investit plus de CHF 1 milllion dans Plair | GGBa","description":"Le leader mondial du diagnostic in vitro bioM\u00e9rieux a investi plus d'un million de francs suisses dans la scale-up Plair.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/","og_locale":"fr_FR","og_type":"article","og_title":"bioM\u00e9rieux investit plus de CHF 1 milllion dans Plair | GGBa","og_description":"Le leader mondial du diagnostic in vitro bioM\u00e9rieux a investi plus d'un million de francs suisses dans la scale-up Plair.","og_url":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-03-30T06:49:11+00:00","article_modified_time":"2026-03-30T06:53:09+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Plair-Rapid-C-Plus-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"bioM\u00e9rieux investit dans Plair pour moderniser la surveillance pharmaceutique","datePublished":"2026-03-30T06:49:11+00:00","dateModified":"2026-03-30T06:53:09+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/"},"wordCount":392,"image":{"@id":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Plair-Rapid-C-Plus-1180x811-1.png","keywords":["Biotech","Diagnostic","Healthcare","Infrastructures","Manufacturing","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/","url":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/","name":"bioM\u00e9rieux investit plus de CHF 1 milllion dans Plair | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Plair-Rapid-C-Plus-1180x811-1.png","datePublished":"2026-03-30T06:49:11+00:00","dateModified":"2026-03-30T06:53:09+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Le leader mondial du diagnostic in vitro bioM\u00e9rieux a investi plus d'un million de francs suisses dans la scale-up Plair.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Plair-Rapid-C-Plus-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/03\/Plair-Rapid-C-Plus-1180x811-1.png","width":1180,"height":811,"caption":"Le syst\u00e8me RAPID-C+ de Plair combine le comptage en temps r\u00e9el des particules viables et totales avec un \u00e9chantillonnage continu certifi\u00e9 sur des milieux g\u00e9los\u00e9s standards, permettant une identification microbienne et une prise de d\u00e9cision plus rapide et mieux inform\u00e9e dans les environnements de salles blanches pharmaceutiques. | \u00a9 Plair"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/biomerieux-investit-dans-plair-pour-moderniser-la-surveillance-pharmaceutique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"bioM\u00e9rieux investit dans Plair pour moderniser la surveillance pharmaceutique"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/38315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=38315"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/38315\/revisions"}],"predecessor-version":[{"id":38317,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/38315\/revisions\/38317"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/38312"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=38315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=38315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=38315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}